<SEC-DOCUMENT>0001140361-21-038578.txt : 20211118
<SEC-HEADER>0001140361-21-038578.hdr.sgml : 20211118
<ACCEPTANCE-DATETIME>20211118165156
ACCESSION NUMBER:		0001140361-21-038578
CONFORMED SUBMISSION TYPE:	8-A12B/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20211118
DATE AS OF CHANGE:		20211118

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Brooklyn ImmunoTherapeutics, Inc.
		CENTRAL INDEX KEY:			0000748592
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				311103425
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-A12B/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11460
		FILM NUMBER:		211425078

	BUSINESS ADDRESS:	
		STREET 1:		140 58TH STREET, BUILDING A
		STREET 2:		SUITE 2100
		CITY:			BROOKLYN
		STATE:			NY
		ZIP:			11220
		BUSINESS PHONE:		(212) 582-1199

	MAIL ADDRESS:	
		STREET 1:		140 58TH STREET, BUILDING A
		STREET 2:		SUITE 2100
		CITY:			BROOKLYN
		STATE:			NY
		ZIP:			11220

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NTN BUZZTIME INC
		DATE OF NAME CHANGE:	20051230

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NTN COMMUNICATIONS INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ALROY INDUSTRIES INC
		DATE OF NAME CHANGE:	19850411
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-A12B/A
<SEQUENCE>1
<FILENAME>ny20001244x2_8a12b.htm
<DESCRIPTION>8-A12B
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using EDGARfilings PROfile 7.7.0.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <div style="text-align: center; margin-left: 0.1pt; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold;">
      <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;" align="center">UNITED STATES</div>
    <div style="text-align: center; margin-left: 0.1pt; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
    <div style="text-align: center; margin-left: 0.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>
    <div><br>
    </div>
    <div style="text-align: center; margin-left: 0.1pt; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 18pt; font-weight: bold;">FORM 8-A/A</div>
    <div style="text-align: center; margin-left: 0.2pt; color: #000000; font-weight: bold;">(Amendment No. 1)</div>
    <div><br>
    </div>
    <div style="text-align: center; margin-left: 0.1pt; color: #000000; font-weight: bold;">FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES</div>
    <div style="text-align: center; margin-left: 0.2pt; color: #000000; font-weight: bold;">PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934</div>
    <div><br>
    </div>
    <div style="text-align: center; margin-left: 0.1pt; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 24pt; font-weight: bold;">Brooklyn ImmunoTherapeutics, Inc.</div>
    <div style="text-align: center; margin-left: 0.1pt; color: #000000; font-style: italic;">(Exact name of registrant as specified in its charter)</div>
    <div><br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z39095361a38e49c6b4f604986962554b" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td rowspan="1" style="width: 50%; vertical-align: top;">
            <div style="text-align: center; color: #000000; font-weight: bold;">Delaware</div>
          </td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: center; color: #000000; font-weight: bold;">31-1103425</div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 50%; vertical-align: top;">
            <div style="text-align: center; color: #000000; font-style: italic;">(State or incorporation or organization)</div>
          </td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: center; color: #000000; font-style: italic;">(I.R.S. Employer Identification No.)</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zb46d4c8e23d34f2991953ddbe4d29273" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td rowspan="1" style="width: 50%; vertical-align: top;">
            <div style="text-align: center; color: #000000; font-weight: bold;">140 58th Street, Building A, Suite 2100</div>
            <div style="text-align: center; color: #000000; font-weight: bold;">Brooklyn, New York</div>
          </td>
          <td style="width: 50%; vertical-align: bottom;">
            <div style="text-align: center; color: #000000; font-weight: bold;">11220</div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 50%; vertical-align: top;">
            <div style="text-align: center; color: #000000; font-style: italic;">(Address of principal executive offices)</div>
          </td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: center; color: #000000; font-style: italic;">(Zip Code)</div>
          </td>
        </tr>

    </table>
    <br>
    <div style="text-align: center; margin-left: 0.1pt; color: #000000;">Securities to be registered pursuant to Section 12(b) of the Act:</div>
    <div><br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z6ec18fec11e24018a62d34c3e606ca0b" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td rowspan="1" style="width: 50%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" nowrap="nowrap">
            <div style="text-align: center; color: #000000;">Title of each class to be so registered</div>
          </td>
          <td style="width: 50%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" nowrap="nowrap">
            <div style="text-align: center; color: #000000;">Name of each exchange on which each class is to be registered</div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 50%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: #000000; font-weight: bold;">Common stock, par value $0.005 per share</div>
          </td>
          <td style="width: 50%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: #000000; font-weight: bold;">The Nasdaq Stock Market LLC</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; margin-left: 0.2pt; color: #000000;">If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check
      the following box. <font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9746;</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; margin-left: 0.2pt; color: #000000;">If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check
      the following box. <font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; margin-left: 0.2pt; color: #000000;">If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. <font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; margin-left: 0.2pt; color: #000000;">Securities Act registration statement file number to which this form relates: <font style="font-weight: bold;">Not applicable</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; margin-left: 0.2pt; color: #000000;">Securities to be registered pursuant to Section 12(g) of the Act: <font style="font-weight: bold;">None.</font></div>
    <div style="text-align: justify; margin-left: 0.2pt; color: #000000;"><font style="font-weight: bold;"> <br>
      </font></div>
    <div style="text-align: justify; margin-left: 0.2pt; color: #000000;">
      <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" align="center"><font style="font-weight: bold;">
      </font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-align: center; margin-left: 0.2pt; color: #000000; font-weight: bold;">EXPLANATORY NOTE</div>
    <div><br>
    </div>
    <div style="text-align: justify; color: #000000;">On October 22, 2021, Brooklyn ImmunoTherapeutics, Inc. (the &#8220;Company&#8221;) filed a Registration Statement on Form 8&#8209;A with the Securities and Exchange Commission in connection with the transfer of the
      listing of the Company&#8217;s common stock, par value $0.005 per share (&#8220;Common Stock&#8221;), from the NYSE American stock exchange to The Nasdaq Global Market. This Amendment No. 1 on Form 8-A/A amends and restates such Registration Statement on Form 8&#8209;A for
      the purpose of updating the source of the description of the Common Stock in Item 1.</div>
    <div style="text-align: justify; color: #000000;"> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zef212405e25d4ced8777cca1532bad8e" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Item 1.</div>
          </td>
          <td style="width: 92.31%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Description of Registrant&#8217;s Securities to be Registered.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; margin-left: 0.1pt; color: #000000;">The description of the Common Stock included under the caption &#8220;Description of Capital Stock&#8221; in the Prospectus forming a part of the Company&#8217;s Registration Statement on Form S-1,
      originally filed with the Securities and Exchange Commission on April 30, 2021 (File No. 333-255694), is hereby incorporated by reference herein. In addition, the above-referenced description included in any Prospectus relating to such Registration
      Statement on Form S-1 filed with the Securities and Exchange Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended, shall be deemed to be incorporated by reference herein.</div>
    <div><br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z84fcc0fb7dc549b78b525965c472c729" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 7.69%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Item 2.</div>
          </td>
          <td style="width: 92.31%; vertical-align: top;">
            <div style="color: #000000; font-weight: bold;">Exhibits.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; margin-left: 0.3pt; color: #000000;">In accordance with the &#8220;Instructions as to Exhibits&#8221; with respect to Form 8-A, no exhibits are required to be filed herewith because no other securities of the Company are registered
      on The Nasdaq Global Market and the securities being registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-align: center; margin-left: 0.2pt; color: #000000; font-weight: bold;">SIGNATURE</div>
    <div><br>
    </div>
    <div style="text-align: justify; margin-left: 0.1pt; color: #000000;">Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Company has duly caused this Amendment No. 1 on Form 8-A/A to be signed on its behalf by the
      undersigned, thereunto duly authorized.</div>
    <div><br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zdce57df1370e42a8b987ecbc26e2cd95" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 49.65%; vertical-align: bottom;">
            <div style="text-indent: -10pt; margin-left: 10pt; color: #000000;">Date: November 18, 2021</div>
          </td>
          <td colspan="2" style="vertical-align: bottom;">
            <div style="text-indent: -10pt; margin-left: 10pt; color: #000000; font-weight: bold;">Brooklyn ImmunoTherapeutics, Inc.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.65%; vertical-align: bottom;">&#160;</td>
          <td colspan="2" style="vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 49.65%; vertical-align: bottom;">&#160;</td>
          <td style="width: 5%; vertical-align: bottom;">
            <div style="text-indent: -10pt; margin-left: 10pt; color: #000000;">By:</div>
          </td>
          <td style="width: 44.64%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="color: #000000;">/s/ Howard J. Federoff</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.65%; vertical-align: bottom;">&#160;</td>
          <td style="width: 5%; vertical-align: bottom;">&#160;</td>
          <td style="width: 44.64%; vertical-align: bottom;">
            <div style="text-indent: -10pt; margin-left: 10pt; color: #000000;">Howard J. Federoff</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.65%; vertical-align: bottom;">&#160;</td>
          <td style="width: 5%; vertical-align: bottom;">&#160;</td>
          <td style="width: 44.64%; vertical-align: bottom;">
            <div style="text-indent: -10pt; margin-left: 10pt; color: #000000;">Chief Executive Officer and President</div>
          </td>
        </tr>

    </table>
    <br>
    <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
